A
Agilent Technologies, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth +6.2% ·
share flow +4.7% ·
net new positions +5.9%
— formula
Broad accumulation — rising shares across more holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 164 | +3 | 194.45M | $25.84B | +9 | −7 |
| Q1 2026 | 165 | -3 | 181.10M | $20.68B | +3 | −7 |
| Q4 2025 | 167 | +1 | 200.20M | $27.23B | +3 | −1 |
| Q3 2025 | 22 | +2 | 109.95M | $14.10B | +3 | −2 |
| Q2 2025 | 18 | -1 | 102.37M | $12.08B | — | −1 |
| Q1 2025 | 16 | -1 | 41.13M | $4.81B | — | −1 |
| Q4 2024 | 17 | +1 | 41.24M | $5.54B | +2 | −1 |
| Q3 2024 | 15 | -1 | 26.67M | $3.96B | +1 | −2 |
| Q2 2024 | 16 | — | 29.82M | $3.86B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 12.71M | — | $1.71B | 0.1% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 9.31M | +0.7% | $1.25B | 0.2% | ▲ Add | 3 | SEC ↗ ×8 |
| 3 | Geode Capital Management ✦ (passive) | 7.00M | +0.8% | $938.29M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 4 | Norges Bank ✦ (passive) | 3.40M | +9.3% | $456.96M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.86M | +498.2% | $249.89M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 6 | PRIMECAP Management ✦ | 1.79M | -6.1% | $240.42M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 7 | T. Rowe Price ✦ | 1.10M | -58.1% | $147.82M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 8 | Citadel Advisors ✦ | 909.90K | +300.7% | $122.24M | 0.1% | ▲ Add | 3 | SEC ↗ ×2 |
| 9 | Marshall Wace ✦ | 806.89K | +280.3% | $108.40M | 0.1% | ▲ Add | 3 | SEC ↗ ×3 |
| 10 | Two Sigma Investments ✦ | 769.90K | +345.9% | $103.43M | 0.2% | ▲ Add | 3 | SEC ↗ |
| 11 | Point72 Asset Management ✦ | 724.91K | New | $97.38M | 0.3% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 433.31K | +38.6% | $58.21M | 0.1% | ▲ Add | 3 | SEC ↗ ×5 |
| 13 | Adage Capital Partners ✦ | 218.49K | +9.2% | $29.35M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 148.34K | -40.4% | $19.93M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 38.20K | +183.7% | $5.13M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 16 | Gotham Asset Management ✦ | 5.71K | -72.5% | $766,947 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 4.95K | New | $664,764 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $97.38M | 0.3% |
| Fisher Asset Management | $664,764 | 0.0% |
Exited
| Harris Associates (Oakmark) | $166.11M | was 0.3% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,065 holders, 251.21M shares, $26.86B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 634 sh · $95,972
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology